共 105 条
[1]
Mathew V(2004)Outcomes in patients with diabetes mellitus undergoing percutaneous coronary intervention in the current era: a report from the prevention of REStenosis with Tranilast and its outcomes (PRESTO) trial Circulation 109 476-480
[2]
Gersh BJ(2002)Comparison of in-hospital and one-year outcomes in patients with and without diabetes mellitus undergoing percutaneous catheter intervention (from the national, heart, lung, and blood institute dynamic registry) Am J Cardiol 90 1062-1067
[3]
Williams BA(2004)Impact of mild or moderate chronic kidney disease on the frequency of restenosis: results from the PRESTO trial J Am Coll Cardiol 44 1786-1791
[4]
Laskey WK(2010)Long-term mortality after PCI in patients with diabetes mellitus: results from the Swedish coronary angiography and angioplasty registry EuroIntervention 5 891-897
[5]
Willerson JT(2011)Impact of chronic kidney disease on the prognosis of patients undergoing percutaneous coronary interventions using drug-eluting stents Clin Res Cardiol 100 1103-1109
[6]
Laskey WK(2005)Association of chronic kidney disease with clinical outcomes after coronary revascularization: the arterial revascularization therapies study (ARTS) Am Heart J 149 512-519
[7]
Seizer F(2002)Clinical outcome following percutaneous coronary interventions in patients with chronic renal failure Catheter Cardiovasc Interv 55 66-72
[8]
Viachos HA(2011)Long-term impact of chronic kidney disease in patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention: the HORIZONS-AMI (harmonizing outcomes with revascularization and stents in acute myocardial infarction) trial JACC Cardiovasc Interv 4 1011-1019
[9]
Johnston J(2011)Characteristics and in-hospital outcomes of patients with non-ST-segment elevation myocardial infarction and chronic kidney disease undergoing percutaneous coronary intervention JACC Cardiovasc Interv 4 1002-1008
[10]
Jacobs A(2015)Temporal trends in management and outcome of diabetic and non-diabetic patients with acute coronary syndrome (ACS): residual risk of long-term mortality persists: insights from the ACS Israeli survey (ACSIS) 2000-2010 Int J Cardiol 179 546-551